| Tzeng CR |
------>authors3_c= ------>paper_class1=1 ------>Impact_Factor=1.144 ------>paper_class3=2 ------>paper_class2=1 ------>vol=100 ------>confirm_bywho=tzengcr ------>insert_bywho=tzengcr ------>Jurnal_Rank=68.3 ------>authors4_c= ------>comm_author= ------>patent_EDate=None ------>authors5_c= ------>publish_day=1 ------>paper_class2Letter=None ------>page2=274 ------>medlineContent= ------>unit=E0111 ------>insert_date=20071204 ------>iam=1 ------>update_date=None ------>author=??? ------>change_event=4 ------>ISSN= ------>authors_c= ------>score=421 ------>journal_name=Int J Gynecol Obstet 2008 Mar; ------>paper_name=Effect of lower-does cetrorelix acetate protocol on in-vitro fertilization outcome ------>confirm_date=20081225 ------>tch_id=079009 ------>pmid=18045601 ------>page1=271 ------>fullAbstract=OBJECTIVE: To determine whether a low initial dosage of cetrorelix acetate could prevent a premature luteinizing hormone (LH) surge in women undergoing controlled ovarian stimulation. METHOD: Treatment with a recombinant follicle stimulating hormone was started on Day 3 of the menstrual cycle, and 0.125 mg of cetrorelix was injected daily from Day 5 of the ovarian stimulation until the diameter of the dominant follicle reached at least 16 mm. The dosage was then doubled and maintained at 0.250 mg/day until the day before the injection of human chorionic gonadotropin. RESULT: There was a significant decrease in serum LH concentration 1 day after doubling the cetrorelix dosage, and the LH concentration remained low during the follicular phase. Clinical pregnancy occurred in 18 women (42.8%), with 2 intrauterine fetal deaths before the 12th week. CONCLUSION: Increasing the cetrorelix dosage from 0.125 to 0.250 mg/day when the follicular size is appropriate can prevent a premature LH surge. ------>tmu_sno=None ------>sno=16332 ------>authors2=Chen HJ ------>authors3=Lin YH ------>authors4=Hsieh BC ------>authors5=Huang LW ------>authors6=Hwang JL ------>authors6_c= ------>authors=Tzeng CR ------>delete_flag=0 ------>SCI_JNo=None ------>authors2_c= ------>publish_area=0 ------>updateTitle=Effect of a lower-dose cetrorelix acetate protocol on in-vitro fertilization outcome. ------>language=2 ------>check_flag=None ------>submit_date=None ------>country=None ------>no=3 ------>patent_SDate=None ------>update_bywho=None ------>publish_year=2008 ------>submit_flag=None ------>publish_month=3 |